This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).

No content found

Data pager
Data pager
12
 Item 1 to 99 of 186
of 2 
Show all 186
Data pager
Data pager
12
 Item 1 to 99 of 186
of 2 
Show all 186
Sunday, March 24 | 4:00PM - 8:00PM
Arrival and Registration
Room: Macdonald Foyer


Sunday, March 24 | 6:00PM - 8:00PM
Welcome Mixer
Room: Macdonald Foyer
No registration fees are used to fund alcohol served at this function.

Monday, March 25 | 7:00AM - 8:00AM
Breakfast
Room: Frontenac/Empress


Monday, March 25 | 8:00AM - 9:15AM
Welcome and Keynote Session (Joint)
Room: Macdonald ABCD

Speaker 1 of 4
* Ann J. Hessell, Oregon Health & Science University, USA

Monday, March 25 | 8:00AM - 9:15AM
Welcome and Keynote Session (Joint)
Room: Macdonald ABCD

Speaker 2 of 4
* Sharon R. Lewin, University of Melbourne, Australia

Monday, March 25 | 8:00AM - 9:15AM
Welcome and Keynote Session (Joint)
Room: Macdonald ABCD

Speaker 3 of 4
John R. Mascola, NIAID, National Institutes of Health, USA
Challenges and Opportunities for Antibody-Based HIV Vaccines

Monday, March 25 | 8:00AM - 9:15AM
Welcome and Keynote Session (Joint)
Room: Macdonald ABCD

Speaker 4 of 4
Robert F. Siliciano, Johns Hopkins University School of Medicine, USA
Understanding Barriers to HIV Cure

Monday, March 25 | 9:15AM - 11:15AM
Antibodies for Prevention, Treatment and Cure (Joint)
Room: Macdonald ABCD

Speaker 1 of 7
* Sharon R. Lewin, University of Melbourne, Australia

Monday, March 25 | 9:15AM - 11:15AM
Antibodies for Prevention, Treatment and Cure (Joint)
Room: Macdonald ABCD

Speaker 2 of 7
* Ann J. Hessell, Oregon Health & Science University, USA

Monday, March 25 | 9:15AM - 11:15AM
Antibodies for Prevention, Treatment and Cure (Joint)
Room: Macdonald ABCD

Speaker 3 of 7
David D. Ho, Aaron Diamond AIDS Research Center (ADARC), Columbia University Medical Center, USA
Engineering Bispecific Antibodies to Prevent/Treat HIV Infection, Quantify Fc-Mediated Effector Functions, Measure Avidity Contribution to Virus Neutralization, and Infer HIV Envelope Spike Density

Monday, March 25 | 9:15AM - 11:15AM
Antibodies for Prevention, Treatment and Cure (Joint)
Room: Macdonald ABCD


Coffee Break

Monday, March 25 | 9:15AM - 11:15AM
Antibodies for Prevention, Treatment and Cure (Joint)
Room: Macdonald ABCD

Speaker 5 of 7
Florian Klein, University of Cologne, Germany
Broadly Neutralizing Antibodies for HIV-1 Immunotherapy

Monday, March 25 | 9:15AM - 11:15AM
Antibodies for Prevention, Treatment and Cure (Joint)
Room: Macdonald ABCD

Speaker 6 of 7
Ann Marie Carias, Northwestern University, USA
Short Talk: Distribution and Localization of I.V. injected VRC01 and VRC01-LS in the in vivo Rhesus Macaque Model

Monday, March 25 | 9:15AM - 11:15AM
Antibodies for Prevention, Treatment and Cure (Joint)
Room: Macdonald ABCD

Speaker 7 of 7
Sai Priya Anand, McGill University, Canada
Short Talk: Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells

Monday, March 25 | 11:15AM - 5:00PM
On Own for Lunch


Monday, March 25 | 11:15AM - 1:00PM
Poster Setup
Room: Frontenac/Empress


Monday, March 25 | 1:00PM - 10:00PM
Poster Viewing
Room: Frontenac/Empress


Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Lessons from Non-Human Primate Studies
Room: Macdonald AB

Speaker 1 of 9
* Willy Bogers, Biomedical Primate Research Centre, Netherlands

Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Lessons from Non-Human Primate Studies
Room: Macdonald AB

Speaker 2 of 9
* Yuxing Li, University of Maryland, USA

Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Lessons from Non-Human Primate Studies
Room: Macdonald AB

Speaker 3 of 9
Bridget Fisher, Seattle Children's Research Institute, USA
Oral Immunization with Native-Like HIV-1 Trimers Elicits Systemic Immune Responses and Cross-Clade Reactive Anti-V1V2 Antibodies

Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Lessons from Non-Human Primate Studies
Room: Macdonald AB

Speaker 4 of 9
Miroslaw K. Gorny, New York University School of Medicine, USA
Tight Control of SHIV Challenge in Macaques with Vaccine-Induced Neutralizing and Non-Neutralizing Anti-V2 Antibodies

Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Lessons from Non-Human Primate Studies
Room: Macdonald AB

Speaker 5 of 9
Paolo Lusso, NIAID, National Institutes of Health, USA
Induction of Cross-Clade Heterologous Tier-2 HIV-1 Neutralizing Antibodies by an mRNA-Based Vaccine in Macaques

Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Lessons from Non-Human Primate Studies
Room: Macdonald AB

Speaker 6 of 9
Ma Luo, University of Manitoba, Canada
A Vaccine Targeting HIV Maturation Protects Cynomolgus Monkeys Against Vaginal SIVmac251 Acquisition

Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Lessons from Non-Human Primate Studies
Room: Macdonald AB

Speaker 7 of 9
Mauricio A. Martins, University of Miami, USA
Anti-CTLA-4 Therapy Enhances Vaccine Immunogenicity but not Efficacy Against Simian Immunodeficiency Virus Challenge in Rhesus Macaques

Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Lessons from Non-Human Primate Studies
Room: Macdonald AB

Speaker 8 of 9
Kimberly M. Cirelli, La Jolla Institute for Immunology, USA
Slow Delivery Immunization Enhances Germinal Center and Neutralizing Antibody Responses via Modulation of Immunodominance

Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Lessons from Non-Human Primate Studies
Room: Macdonald AB

Speaker 9 of 9
Mario Roederer, NIAID, National Institutes of Health, USA
SIV Escapes from Non-neutralizing Antibodies Blocking a4ß7 Integrin Binding

Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Immunology of HIV Cure
This session is from HIV Cures
Room: Macdonald CD

Speaker 1 of 10
* Leor S. Weinberger, University of California, San Francisco, USA


Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Immunology of HIV Cure
This session is from HIV Cures
Room: Macdonald CD

Speaker 2 of 10
* Rasmi Thomas, U.S. Military HIV Research Program, USA


Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Immunology of HIV Cure
This session is from HIV Cures
Room: Macdonald CD

Speaker 3 of 10
James Arthos, NIAID, National Institutes of Health, USA
A Role for MAdCAM and Retinoic Acid in Establishing Viral Replication in Gut-Associated Lymphoid Tissues


Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Immunology of HIV Cure
This session is from HIV Cures
Room: Macdonald CD

Speaker 4 of 10
Evan Rossignol, Ragon Institute of MGH, MIT, and Harvard, USA
Development of Monoclonal Antibodies from Elite Controllers to Target the HIV Reservoir


Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Immunology of HIV Cure
This session is from HIV Cures
Room: Macdonald CD

Speaker 5 of 10
Anjie Zhen, University of California, Los Angeles, USA
Checkpoint Inhibitor Dendritic Cell Vaccine Suppresses HIV-1 Replication


Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Immunology of HIV Cure
This session is from HIV Cures
Room: Macdonald CD

Speaker 6 of 10
David F. G. Malone, University of Oxford, UK
CD56neg NK Cells Have Increased Functional Response to CD16 Stimulation in Chronic HIV


Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Immunology of HIV Cure
This session is from HIV Cures
Room: Macdonald CD

Speaker 7 of 10
Riddhima Banga, Centre Hospitalier Universitaire Vaudois, Switzerland
PD-1/PD-L1 Interaction Modulates HIV-1 Transcription in Lymph Nodes of Treated Aviremic Individuals


Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Immunology of HIV Cure
This session is from HIV Cures
Room: Macdonald CD

Speaker 8 of 10
Namita Satija, Icahn School of Medicine at Mount Sinai, USA
A Genetically Encoded Switch to Monitor HIV Infection and Latency within Humanized Mice Reveals HIV-Susceptibility Associated with Diverse T Cell Transcriptional States


Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Immunology of HIV Cure
This session is from HIV Cures
Room: Macdonald CD

Speaker 9 of 10
Carly G K Ziegler, Massachusetts Institute of Technology, USA
Paired Host-Virus Single Cell Genomics Identifies Cell Types Harboring Virus in Humans and Non-Human Primates


Monday, March 25 | 2:30PM - 4:30PM
Workshop 1: Immunology of HIV Cure
This session is from HIV Cures
Room: Macdonald CD

Speaker 10 of 10
Alexander O. Pasternak, University of Amsterdam, Netherlands
CD32+CD4+ T Cells Are Highly Enriched in HIV DNA


Monday, March 25 | 4:30PM - 5:00PM
Coffee Available
Room: Macdonald Foyer


Monday, March 25 | 5:00PM - 7:00PM
Clinical Trials for Prevention: Vaccines and Antibodies
Room: Macdonald AB

Speaker 1 of 7
* Punnee Pitisuttithum, Mahidol University, Thailand

Monday, March 25 | 5:00PM - 7:00PM
Clinical Trials for Prevention: Vaccines and Antibodies
Room: Macdonald AB

Speaker 2 of 7
* Susan W. Barnett, Bill & Melinda Gates Foundation, USA

Monday, March 25 | 5:00PM - 7:00PM
Clinical Trials for Prevention: Vaccines and Antibodies
Room: Macdonald AB

Speaker 3 of 7
Fatima Laher, University of the Witwatersrand, South Africa
ALVAC-gp120 for Clade C in South Africa

Monday, March 25 | 5:00PM - 7:00PM
Clinical Trials for Prevention: Vaccines and Antibodies
Room: Macdonald AB

Speaker 4 of 7
Shelly Krebs, Walter Reed Army Institute of Research, USA
Short Talk: B Cell Priming from RV144 Vaccination Impacts Post-Infection Antibody Responses

Monday, March 25 | 5:00PM - 7:00PM
Clinical Trials for Prevention: Vaccines and Antibodies
Room: Macdonald AB

Speaker 5 of 7
Lawrence Corey, Fred Hutchinson Cancer Research Center, USA
Validating Neutralization as a Mechanistic Surrogate of Protection in Passive Antibody Studies

Monday, March 25 | 5:00PM - 7:00PM
Clinical Trials for Prevention: Vaccines and Antibodies
Room: Macdonald AB

Speaker 6 of 7
Beatrice Ondondo, Cardiff Metropolitan University, UK
T-Cell Vaccine Trials for HIV

Monday, March 25 | 5:00PM - 7:00PM
Clinical Trials for Prevention: Vaccines and Antibodies
Room: Macdonald AB

Speaker 7 of 7
R. Keith Reeves, Harvard Medical School, USA
Short Talk: Human Memory NK Cells Are Potently Induced by HIV and HIV Vaccines

Monday, March 25 | 5:00PM - 7:00PM
Development of the Innate Cell and Antibody Responses to HIV
This session is from HIV Cures
Room: Macdonald CD

Speaker 1 of 8
* Rebecca M. Lynch, George Washington University, USA


Monday, March 25 | 5:00PM - 7:00PM
Development of the Innate Cell and Antibody Responses to HIV
This session is from HIV Cures
Room: Macdonald CD

Speaker 2 of 8
* Brian Moldt, Gilead Sciences, USA


Monday, March 25 | 5:00PM - 7:00PM
Development of the Innate Cell and Antibody Responses to HIV
This session is from HIV Cures
Room: Macdonald CD

Speaker 3 of 8
Galit Alter, MIT and Harvard University, USA
Defining Conserved Correlates of Humoral Immune Protection Against SIV/SHIV


Monday, March 25 | 5:00PM - 7:00PM
Development of the Innate Cell and Antibody Responses to HIV
This session is from HIV Cures
Room: Macdonald CD

Speaker 4 of 8
Michel C. Nussenzweig, HHMI/Rockefeller University, USA
Targeting B Lymphocytes to Control HIV-1


Monday, March 25 | 5:00PM - 7:00PM
Development of the Innate Cell and Antibody Responses to HIV
This session is from HIV Cures
Room: Macdonald CD

Speaker 5 of 8
Mario Roederer, NIAID, National Institutes of Health, USA
Short Talk: SIV Escapes from Non-neutralizing Antibodies Blocking a4ß7 Integrin Binding


Monday, March 25 | 5:00PM - 7:00PM
Development of the Innate Cell and Antibody Responses to HIV
This session is from HIV Cures
Room: Macdonald CD

Speaker 6 of 8
Jérémy Dufloo, Institut Pasteur, France
Short Talk: Complement Activation at the Surface of HIV-1-Infected Cells


Monday, March 25 | 5:00PM - 7:00PM
Development of the Innate Cell and Antibody Responses to HIV
This session is from HIV Cures
Room: Macdonald CD

Speaker 7 of 8
Mariya B. Shapiro, Oregon Health & Science University, USA
Short Talk: Defining the Window of Opportunity for SHIV Clearance with bNAbs in Infant Macaques


Monday, March 25 | 5:00PM - 7:00PM
Development of the Innate Cell and Antibody Responses to HIV
This session is from HIV Cures
Room: Macdonald CD

Speaker 8 of 8
Lynn Morris, National Institute for Communicable Diseases, South Africa
Genetic and Structural Features of HIV-1 V2-Specific Antibodies that Mediate ADCC and Block a4ß7 Interactions


Monday, March 25 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Frontenac/Empress
No registration fees are used to fund alcohol served at this function.

Monday, March 25 | 7:30PM - 10:00PM
Poster Session 1
Room: Frontenac/Empress


Tuesday, March 26 | 7:00AM - 8:00AM
Breakfast
Room: Frontenac/Empress


Tuesday, March 26 | 8:00AM - 11:15AM
New Technologies for Studying and Inducing B Cells
Room: Macdonald AB

Speaker 1 of 10
* Ivelin Georgiev, Vanderbilt Vaccine Center, USA

Tuesday, March 26 | 8:00AM - 11:15AM
New Technologies for Studying and Inducing B Cells
Room: Macdonald AB

Speaker 2 of 10
* Andrew B. Ward, The Scripps Research Institute, USA

Tuesday, March 26 | 8:00AM - 11:15AM
New Technologies for Studying and Inducing B Cells
Room: Macdonald AB

Speaker 3 of 10
Gunilla B. Karlsson Hedestam, Karolinska Institutet, Sweden
Antibody Germline Genes and Impact on Vaccine Responses

Tuesday, March 26 | 8:00AM - 11:15AM
New Technologies for Studying and Inducing B Cells
Room: Macdonald AB

Speaker 4 of 10
Steven E. Bosinger, Emory University, USA
In vivo Lineage Tracing of Antigen-Specific B Cells after Vaccination

Tuesday, March 26 | 8:00AM - 11:15AM
New Technologies for Studying and Inducing B Cells
Room: Macdonald AB

Speaker 5 of 10
Ian Setliff, Vanderbilt Vaccine Center, USA
Short Talk: High-Throughput Mapping of B-Cell Receptor Sequence to Antigen Specificity

Tuesday, March 26 | 8:00AM - 11:15AM
New Technologies for Studying and Inducing B Cells
Room: Macdonald AB


Coffee Break

Tuesday, March 26 | 8:00AM - 11:15AM
New Technologies for Studying and Inducing B Cells
Room: Macdonald AB

Speaker 7 of 10
James E. Voss, The Scripps Research Institute, USA
Short Talk: Reprogramming the Antigen Specificity of B Cells Using Genome-Editing Technologies

Tuesday, March 26 | 8:00AM - 11:15AM
New Technologies for Studying and Inducing B Cells
Room: Macdonald AB

Speaker 8 of 10
Adrian B. McDermott, National Institutes of Health, USA
Characterization of Antigen-Specific Memory B Cells Following Vaccination

Tuesday, March 26 | 8:00AM - 11:15AM
New Technologies for Studying and Inducing B Cells
Room: Macdonald AB

Speaker 9 of 10
Colin Havenar-Daughton, Vir Biotechnology, USA
The Antigen-Specific Human Naive B Cell Repertoire: A Starting Point for Vaccine Responses

Tuesday, March 26 | 8:00AM - 11:15AM
New Technologies for Studying and Inducing B Cells
Room: Macdonald AB

Speaker 10 of 10
Kristin L. Boswell, NIAID, National Institutes of Health, USA
Short Talk: Bcl-6/Bcl-xL B Cell Immortalization for Antibody Discovery in Vaccination and Chronic Infection

Tuesday, March 26 | 8:00AM - 11:15AM
Mechanisms of Viral Expression and Control of Host Cell Func
tion
This session is from HIV Cures

Room: Macdonald CD

Speaker 1 of 10
* Ya-Chi Ho, Yale School of Medicine, USA


Tuesday, March 26 | 8:00AM - 11:15AM
Mechanisms of Viral Expression and Control of Host Cell Func
tion
This session is from HIV Cures

Room: Macdonald CD

Speaker 2 of 10
* Joseph (Mike) McCune, Bill & Melinda Gates Foundation, USA


Tuesday, March 26 | 8:00AM - 11:15AM
Mechanisms of Viral Expression and Control of Host Cell Func
tion
This session is from HIV Cures

Room: Macdonald CD

Speaker 3 of 10
Saba Valadkhan, Case Western Reserve University, USA
An HIV-Induced Mechanism for T Cell Quiescence and Proviral Latency


Tuesday, March 26 | 8:00AM - 11:15AM
Mechanisms of Viral Expression and Control of Host Cell Func
tion
This session is from HIV Cures

Room: Macdonald CD

Speaker 4 of 10
Eric M. Verdin, Buck Institute for Research on Aging, USA
CRISPR-Based Characterizing of Latency-Associated Pathways


Tuesday, March 26 | 8:00AM - 11:15AM
Mechanisms of Viral Expression and Control of Host Cell Func
tion
This session is from HIV Cures

Room: Macdonald CD


Coffee Break


Tuesday, March 26 | 8:00AM - 11:15AM
Mechanisms of Viral Expression and Control of Host Cell Func
tion
This session is from HIV Cures

Room: Macdonald CD

Speaker 6 of 10
Jonathan Karn, Case Western Reserve University, USA
Signaling Pathways Controlling HIV Reactivation from Latency


Tuesday, March 26 | 8:00AM - 11:15AM
Mechanisms of Viral Expression and Control of Host Cell Func
tion
This session is from HIV Cures

Room: Macdonald CD

Speaker 7 of 10
Ivan D'Orso, University of Texas Southwestern Medical Center, USA
Transcriptional Regulatory Mechanisms Shaping HIV Proviral Fate


Tuesday, March 26 | 8:00AM - 11:15AM
Mechanisms of Viral Expression and Control of Host Cell Func
tion
This session is from HIV Cures

Room: Macdonald CD

Speaker 8 of 10
Joe D. Hiatt, University of California, San Francisco, USA
Short Talk: A Functional Map of HIV-Host Interactions in Primary Human CD4+ T cells


Tuesday, March 26 | 8:00AM - 11:15AM
Mechanisms of Viral Expression and Control of Host Cell Func
tion
This session is from HIV Cures

Room: Macdonald CD

Speaker 9 of 10
Peter D. Sun, NIAID, National Institutes of Health, USA
Short Talk: Target HIV Viral Release Pathway as A New Antiviral Strategy


Tuesday, March 26 | 8:00AM - 11:15AM
Mechanisms of Viral Expression and Control of Host Cell Func
tion
This session is from HIV Cures

Room: Macdonald CD

Speaker 10 of 10
Richard E. Sutton, Yale University School of Medicine, USA
Short Talk: Whole Exome Sequencing Identifies SNVs and Indels Associated with HIV+ Elite and Viremic Control


Tuesday, March 26 | 11:15AM - 5:00PM
On Own for Lunch


Tuesday, March 26 | 11:15AM - 1:00PM
Poster Setup
Room: Frontenac/Empress


Tuesday, March 26 | 11:30AM - 1:00PM
Hands-On Computer Workshop on Los Alamos
HIV Sequences

Database
Room: Macdonald EF
Bring your own laptop if you have one
Click here for more information


Tuesday, March 26 | 1:00PM - 10:00PM
Poster Viewing
Room: Frontenac/Empress


Tuesday, March 26 | 4:30PM - 5:00PM
Coffee Available
Room: Macdonald Foyer


Tuesday, March 26 | 5:00PM - 7:00PM
Antibody-Virus Coevolution: Vaccines and Lessons from Infect
ion

Room: Macdonald AB

Speaker 1 of 6
* Daniela Fera, Swarthmore College, USA

Tuesday, March 26 | 5:00PM - 7:00PM
Antibody-Virus Coevolution: Vaccines and Lessons from Infect
ion

Room: Macdonald AB

Speaker 2 of 6
Nicole A. Doria-Rose, NIAID, National Institutes of Health, USA
Broadly Neutralizing Antibodies: Lessons from Natural Infection

Tuesday, March 26 | 5:00PM - 7:00PM
Antibody-Virus Coevolution: Vaccines and Lessons from Infect
ion

Room: Macdonald AB

Speaker 3 of 6
Kevin O. Saunders, Duke University, USA
Short Talk: CH505 Transmitted/Founder Envelope Elicits Tier 2 Neutralizing Antibodies Against the CD4 Binding and V1V2-Glycan Sites during Human Infection and Macaque Vaccination

Tuesday, March 26 | 5:00PM - 7:00PM
Antibody-Virus Coevolution: Vaccines and Lessons from Infect
ion

Room: Macdonald AB

Speaker 4 of 6
Mattia Bonsignori, Duke University, USA
Inference of the VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier

Tuesday, March 26 | 5:00PM - 7:00PM
Antibody-Virus Coevolution: Vaccines and Lessons from Infect
ion

Room: Macdonald AB

Speaker 5 of 6
Elise Landais, International AIDS Vaccine Initiative, USA
Fast and Focused Maturation of a VRC01-Class Broadly Neutralizing Antibody Lineage

Tuesday, March 26 | 5:00PM - 7:00PM
Antibody-Virus Coevolution: Vaccines and Lessons from Infect
ion

Room: Macdonald AB

Speaker 6 of 6
Marit van Gils, Amsterdam UMC, Netherlands
Short Talk: Comparison of Monoclonal Antibodies Induced by BG505 SOSIP Trimer Immunization and BG505 SHIV Infection in Non-Human Primates

Tuesday, March 26 | 5:00PM - 7:00PM
Mechanism and Modulation of Latency
This session is from HIV Cures
Room: Macdonald CD

Speaker 1 of 7
* George B. Kyei, University of Ghana, Ghana


Tuesday, March 26 | 5:00PM - 7:00PM
Mechanism and Modulation of Latency
This session is from HIV Cures
Room: Macdonald CD

Speaker 2 of 7
* Sharon R. Lewin, University of Melbourne, Australia


Tuesday, March 26 | 5:00PM - 7:00PM
Mechanism and Modulation of Latency
This session is from HIV Cures
Room: Macdonald CD

Speaker 3 of 7
Melanie M. Ott, Gladstone Institutes, USA
Epigenetic Regulation of HIV Transcription


Tuesday, March 26 | 5:00PM - 7:00PM
Mechanism and Modulation of Latency
This session is from HIV Cures
Room: Macdonald CD

Speaker 4 of 7
Monsef Benkirane, Institut de Genetique Humaine, France
HIV-Host Interactions at the Genomic Level


Tuesday, March 26 | 5:00PM - 7:00PM
Mechanism and Modulation of Latency
This session is from HIV Cures
Room: Macdonald CD

Speaker 5 of 7
Leor S. Weinberger, University of California, San Francisco, USA
Discovery and Characterization of a Virus-Intrinsic HIV Latency Circuit


Tuesday, March 26 | 5:00PM - 7:00PM
Mechanism and Modulation of Latency
This session is from HIV Cures
Room: Macdonald CD

Speaker 6 of 7
Luis M. Agosto, Boston Medical Center, USA
Short Talk: Identification of Novel Pathways that Regulate HIV Transcription using an Unbiased Functional Screen


Tuesday, March 26 | 5:00PM - 7:00PM
Mechanism and Modulation of Latency
This session is from HIV Cures
Room: Macdonald CD

Speaker 7 of 7
Leah Plasek, Case Western Reserve University, USA
Short Talk: Investigation of Potential Roles for lncRNAs in Establishment and Maintenance of HIV Latency


Tuesday, March 26 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Frontenac/Empress
No registration fees are used to fund alcohol served at this function.

Tuesday, March 26 | 7:30PM - 10:00PM
Poster Session 2
Room: Frontenac/Empress


Wednesday, March 27 | 7:00AM - 8:00AM
Breakfast
Room: Frontenac/Empress


Wednesday, March 27 | 8:00AM - 11:00AM
Therapeutic Vaccines and Cure Strategies (Joint)
Room: Macdonald ABCD

Speaker 1 of 8
* Douglas F. Nixon, Weill Cornell Medicine, USA

Wednesday, March 27 | 8:00AM - 11:00AM
Therapeutic Vaccines and Cure Strategies (Joint)
Room: Macdonald ABCD

Speaker 2 of 8
* Tomas Hanke, University of Oxford, UK

Wednesday, March 27 | 8:00AM - 11:00AM
Therapeutic Vaccines and Cure Strategies (Joint)
Room: Macdonald ABCD

Speaker 3 of 8
Jintanat Ananworanich, US Military HIV Research Program, USA
AD26 & MVA Vaccines in Acutely Treated HIV: Safety, Immunogenicity and Viral Rebound

No content found

No content found

No content found